Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023		109,103,721
Beginning balance at Dec. 31, 2023	$ 489,648	$ 109	$ 1,142,578	$ (8,649)	$ (644,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,093		32,093
Common stock issued under employee stock plans (in shares)		2,485,389
Common stock issued under employee stock plans	6,414	$ 3	6,411
Taxes related to net share settlement of equity awards	(34,860)		(34,860)
Unrealized income (loss) on derivative instruments, net of tax	1,797			1,797
Unrealized (loss) income on available for sale securities, net of tax	(2,253)			(2,253)
Net loss	(40,490)				(40,490)
Ending balance (in shares) at Mar. 31, 2024		111,589,110
Ending balance at Mar. 31, 2024	452,349	$ 112	1,146,222	(9,105)	(684,880)
Beginning balance (in shares) at Dec. 31, 2023		109,103,721
Beginning balance at Dec. 31, 2023	489,648	$ 109	1,142,578	(8,649)	(644,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized income (loss) on derivative instruments, net of tax	4,550
Unrealized (loss) income on available for sale securities, net of tax	(282)
Net loss	(82,771)
Ending balance (in shares) at Sep. 30, 2024		112,422,071
Ending balance at Sep. 30, 2024	428,560	$ 112	1,159,990	(4,381)	(727,161)
Beginning balance (in shares) at Mar. 31, 2024		111,589,110
Beginning balance at Mar. 31, 2024	452,349	$ 112	1,146,222	(9,105)	(684,880)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	30,089		30,089
Common stock issued under employee stock plans (in shares)		590,312
Common stock issued under employee stock plans	3,378		3,378
Taxes related to net share settlement of equity awards	(1,748)		(1,748)
Unrealized income (loss) on derivative instruments, net of tax	(961)			(961)
Unrealized (loss) income on available for sale securities, net of tax	(559)			(559)
Common stock issued for debt conversion (in shares)		195
Common stock issued for debt conversion	6		6
Net loss	(23,948)				(23,948)
Ending balance (in shares) at Jun. 30, 2024		112,179,617
Ending balance at Jun. 30, 2024	458,606	$ 112	1,177,947	(10,625)	(708,828)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	31,931		31,931
Common stock issued under employee stock plans (in shares)		242,454
Common stock issued under employee stock plans	6,290		6,290
Taxes related to net share settlement of equity awards	(656)		(656)
Unrealized income (loss) on derivative instruments, net of tax	3,714			3,714
Unrealized (loss) income on available for sale securities, net of tax	2,530			2,530
Purchase of capped calls related to Convertible senior notes	(55,522)		(55,522)
Net loss	(18,333)				(18,333)
Ending balance (in shares) at Sep. 30, 2024		112,422,071
Ending balance at Sep. 30, 2024	428,560	$ 112	1,159,990	(4,381)	(727,161)
Beginning balance (in shares) at Dec. 31, 2024		112,550,156
Beginning balance at Dec. 31, 2024	455,656	$ 113	1,193,022	2,676	(740,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,255		32,255
Common stock issued under employee stock plans (in shares)		1,808,876
Common stock issued under employee stock plans	7,163	$ 2	7,161
Taxes related to net share settlement of equity awards	(26,447)		(26,447)
Repurchase of common stock (in shares)		(1,476,456)
Repurchase of common stock	(61,264)	$ (2)	(61,262)
Unrealized income (loss) on derivative instruments, net of tax	(6,231)			(6,231)
Unrealized (loss) income on available for sale securities, net of tax	2,393			2,393
Common stock issued for debt conversion (in shares)		32
Common stock issued for debt conversion	1		1
Net loss	(35,783)				(35,783)
Ending balance (in shares) at Mar. 31, 2025		112,882,608
Ending balance at Mar. 31, 2025	367,743	$ 113	1,144,730	(1,162)	(775,938)
Beginning balance (in shares) at Dec. 31, 2024		112,550,156
Beginning balance at Dec. 31, 2024	455,656	$ 113	1,193,022	2,676	(740,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized income (loss) on derivative instruments, net of tax	12,553
Unrealized (loss) income on available for sale securities, net of tax	3,153
Net loss	(101,549)
Ending balance (in shares) at Sep. 30, 2025		117,897,308
Ending balance at Sep. 30, 2025	604,835	$ 118	1,428,039	18,382	(841,704)
Beginning balance (in shares) at Mar. 31, 2025		112,882,608
Beginning balance at Mar. 31, 2025	367,743	$ 113	1,144,730	(1,162)	(775,938)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	33,859		33,859
Common stock issued under employee stock plans (in shares)		163,501
Taxes related to net share settlement of equity awards	(1,352)		(1,352)
Repurchase of common stock (in shares)		(1,003,885)
Repurchase of common stock	(38,736)	$ (1)	(38,735)
Unrealized income (loss) on derivative instruments, net of tax	15,736			15,736
Unrealized (loss) income on available for sale securities, net of tax	(77)			(77)
Common stock issued for debt conversion (in shares)		4,885
Common stock issued for debt conversion	150		150
Net loss	(35,824)				(35,824)
Ending balance (in shares) at Jun. 30, 2025		112,047,109
Ending balance at Jun. 30, 2025	341,499	$ 112	1,138,652	14,497	(811,762)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	31,550		31,550
Common stock issued under employee stock plans (in shares)		273,665
Common stock issued under employee stock plans	7,186		7,186
Taxes related to net share settlement of equity awards	(631)		(631)
Unrealized income (loss) on derivative instruments, net of tax	3,048			3,048
Unrealized (loss) income on available for sale securities, net of tax	837			837
Common stock issued for debt conversion (in shares)		8,180,968
Common stock issued for debt conversion	251,288	$ 8	251,280
Settlement of capped call transactions (in shares)		(2,604,434)
Settlement of capped call transactions	0	$ (2)	2
Net loss	(29,942)				(29,942)
Ending balance (in shares) at Sep. 30, 2025		117,897,308
Ending balance at Sep. 30, 2025	$ 604,835	$ 118	$ 1,428,039	$ 18,382	$ (841,704)